Topiramate Tablet, Film Coated
Product Images NDC 71335-2318

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-2318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This text provides information on cumulative rates for time to first seizure. It shows data points at 50 mg/day and 400 mg/day of topiramate, with corresponding seizure rates. The text also mentions a p-value of 0.00002, indicating a statistically significant difference between the two dosage groups. Additionally, there is a graph with a time axis in days ranging from 0 to 400.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
Not available.*
FDA Label Image

Label (Lbl713352318)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.